These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25913765)

  • 1. Higher serum insulin-like growth factor-1 is associated with better cognitive performance in persons with mild cognitive impairment.
    Calvo D; Gunstad J; Miller LA; Glickman E; Spitznagel MB
    Psychogeriatrics; 2013 Sep; 13(3):170-4. PubMed ID: 25913765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Huang R; Wang P; Han J; Xia W; Cai R; Sun H; Sun J; Wang S
    J Alzheimers Dis; 2015; 47(1):85-94. PubMed ID: 26402757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of healthy, fit older adults.
    Bellar D; Glickman EL; Juvancic-Heltzel J; Gunstad J
    Neuroscience; 2011 Mar; 178():133-7. PubMed ID: 21256932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
    Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
    Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
    Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
    Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
    Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
    Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor-I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function.
    Kimoto A; Kasanuki K; Kumagai R; Shibata N; Ichimiya Y; Arai H
    Psychogeriatrics; 2016 Jul; 16(4):247-54. PubMed ID: 26439951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    Eur J Neurol; 2014 May; 21(5):802-7. PubMed ID: 23551560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free insulin-like growth factor-I and cognitive function in older persons living in community.
    Landi F; Capoluongo E; Russo A; Onder G; Cesari M; Lulli P; Minucci A; Pahor M; Zuppi C; Bernabei R
    Growth Horm IGF Res; 2007 Feb; 17(1):58-66. PubMed ID: 17208483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
    Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    Vidal JS; Hanon O; Funalot B; Brunel N; Viollet C; Rigaud AS; Seux ML; le-Bouc Y; Epelbaum J; Duron E
    J Alzheimers Dis; 2016 Mar; 52(2):641-9. PubMed ID: 27031487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly.
    Kalmijn S; Janssen JA; Pols HA; Lamberts SW; Breteler MM
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4551-5. PubMed ID: 11134107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
    Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Moderating Role of Insulin-Like Growth Factor 1 in the Relationship Between Cognitive and Aerobic Endurance Change.
    Anderson JR; Calvo D; Glickman E; Gunstad J; Spitznagel MB
    J Geriatr Psychiatry Neurol; 2017 Mar; 30(2):84-89. PubMed ID: 28073325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory identification and cognitive performance in community-dwelling older adults with mild cognitive impairment.
    Makizako M; Makizako H; Doi T; Uemura K; Tsutsumimoto K; Miyaguchi H; Shimada H
    Chem Senses; 2014 Jan; 39(1):39-46. PubMed ID: 24200528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does impaired executive functioning differentially impact verbal memory measures in older adults with suspected dementia?
    Brooks BL; Weaver LE; Scialfa CT
    Clin Neuropsychol; 2006 Jun; 20(2):230-42. PubMed ID: 16690544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed.
    Doi T; Shimada H; Makizako H; Tsutsumimoto K; Hotta R; Nakakubo S; Suzuki T
    Neurobiol Aging; 2015 Feb; 36(2):942-7. PubMed ID: 25467636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study.
    Tumati S; Burger H; Martens S; van der Schouw YT; Aleman A
    PLoS One; 2016; 11(4):e0154450. PubMed ID: 27115487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.